- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04884451
Evaluation of a Stage-Based Tailored, Nutrition Education Package for Childhood Obesity (ST-NEPCO) (7-12 Years Old) (ST-NEPCO)
May 11, 2021 updated by: Nor Baizura Md. Yusop, Universiti Putra Malaysia
A randomized controlled trial will be used to determine the effectiveness of ST-NEPCO.
The study will involve obese children aged 7 to 11 years old.
Participants will be assigned randomly to either the intervention or control group.
The intervention group will receive counselling from the researcher based on ST-NEPCO, meanwhile the control group will receive counseling from dietitians based on the routine care for the management of childhood obesity.
The study will be conducted for duration of 24 weeks.
The individual counseling session will be held once a month for each participant during the weekend.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: nor baizura md yusop
- Phone Number: +603-97692931
- Email: norbaizura@upm.edu.my
Study Locations
-
-
Selangor
-
Serdang, Selangor, Malaysia, 43400
- Recruiting
- Universiti Putra Malaysia Teaching Hospital
-
Contact:
- FARIDZATUL SYUHADA ABDUL RASHID
- Phone Number: +603-9769 9763
- Email: faridzatul@upm.edu.my
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
7 years to 12 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Children aged 7 to 11 years old
- Children classified as obese (>+2SD) based on BMI-for-age for 5 to 19 years old (WHO, 2007).
Exclusion Criteria:
- Children diagnosed with chronic asthma, diabetes mellitus, psychiatric disorders (e.g. schizophrenia, severe autism or mental retardation, or psychosis), or other serious medical conditions.
- Children receiving medications that can potentially promote weight gain or weight loss.
- Children participating in any weight management program
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
Participants will receive nutritional counselling from the researcher based on Stage-Based, Nutrition Education Package for Childhood Obesity (ST-NEPCO).
Nutritional advice and educational tools will be provided according to participants' stages of change.
|
Diet and physical activity modification and behavioral approach
|
|
No Intervention: Control
Participants will receive counseling from dietitians based on the routine care for the management of childhood obesity.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
BMI-for-age z -score change
Time Frame: Change from baseline to week 24
|
BMI-for-age z-score will be calculated using the WHO AnthroPlus software (http://www.who.int/growthref/tools/en) and the WHO 2007 growth reference will be used to determine the BMI-for-age z-score of participants (de Onis et al., 2007).
|
Change from baseline to week 24
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body composition (BMI, Lean Body Mass (LBM), Body Fat Mass (BFM) change
Time Frame: Change from baseline to week 24
|
Body composition was measured using a body composition analyzer (InBody S10®; Biospace Co., Ltd., Seoul, Korea).
This device uses multiple frequencies (1 kHz, 5 kHz, 50 kHz, 250 kHz, 500 kHz, and 1,000 kHz) of BIA technology and contains 8-point tactile electrodes that were attached to the left and right thumb, middle finger, and ankles.
Subjects were in stand position; their arms and legs did not come into contact with each other, and they did not talk or move during the measurement, which lasted 2 minutes.
|
Change from baseline to week 24
|
|
Waist and hip circumferences change
Time Frame: Change from baseline to week 24
|
WC will be measured using a fibreglass tape (measuring tape SECA 201 SECA Vogel and Halke Gmbh & Co., Germany) at the highest point of the iliac crest at minimal respiration when the participant in a standing position.
HC will be obtained at the widest area of hips, which is at the greatest protuberance of the buttocks.
The 90th percentile values for WC for sex and age by Poh et al. (2011) will be used as cut-off values to identify respondents with abdominal obesity.
|
Change from baseline to week 24
|
|
Energy and nutrient intakes [macronutrients, Saturated Fatty Acids (SFA), sugar and dietary fibre] change
Time Frame: Change from baseline to week 24
|
Dietary intake will be obtained using three-day food record at baseline and every follow-up visits.
Participants and parents/caregivers will be taught about portion size estimation and household measurement to fill in the three-day food record.
Pictures from the Atlas of Food Exchanges and Portion Sizes (food album) (Suzana et al., 2002), a set of household measurement tools (glass, soup bowl, plate, cup, teaspoon and tablespoon) and food models will be used to guide parents/caregivers in estimating portion sizes.
|
Change from baseline to week 24
|
|
Physical activity score change
Time Frame: Change from baseline to week 24
|
Physical activity will be assessed using The Physical Activity Questionnaire for Older Children (PAQ-C) (Kowalski et al., 2004).
Subjects will be classified into low, moderate and high physical activity categories with a mean total score ranging from 1.00 to 2.33, 2.34 to 3.66 and 3.67 to 5.00, respectively (Baharudin et al., 2014; Kowalski et al., 2004).
Internal consistency (Cronbach's alpha) calculated from baseline was 0.73.
|
Change from baseline to week 24
|
|
Stage of readiness to lose weight change
Time Frame: Change from baseline to week 24
|
The measurement will be based on the scale for SOC (The S-Weight) to assess the readiness to lose weight for overweight and obese individual.
It consists of five options that are mutually exclusive, among which participants have to choose in order to be allocated to one of the five SOC (Ceccarini, Borrello, Pietrabissa, Manzoni, & Castelnuovo, 2015).
|
Change from baseline to week 24
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 3, 2021
Primary Completion (Anticipated)
November 1, 2021
Study Completion (Anticipated)
December 1, 2021
Study Registration Dates
First Submitted
May 4, 2021
First Submitted That Met QC Criteria
May 11, 2021
First Posted (Actual)
May 13, 2021
Study Record Updates
Last Update Posted (Actual)
May 13, 2021
Last Update Submitted That Met QC Criteria
May 11, 2021
Last Verified
May 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- JKEUPM-2019-375
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lifestyle modification
-
Massachusetts General HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
University of OuluOulu University Hospital; Oulu Deaconess Institute Foundation srCompletedObesity | Physical Activity | Weight Loss | Healthy Obesity, MetabolicallyFinland
-
University of PennsylvaniaSt. Luke's-Roosevelt Hospital CenterCompletedObesity | OverweightUnited States
-
Clínica BazterricaWithdrawn
-
Universität Duisburg-EssenCharite University, Berlin, Germany; University of Witten/Herdecke; Kliniken... and other collaboratorsCompletedHypertension | Metabolic SyndromeGermany
-
Zagazig UniversityCompletedIntermittent Islamic Fasting in Metabolic SyndromeEgypt
-
VA Office of Research and DevelopmentCompletedDiabetes | Impaired Glucose Tolerance | NeuropathyUnited States
-
Medical University of South CarolinaCompletedWeight Loss | Heart Failure, DiastolicUnited States
-
King Abdullah International Medical Research CenterCompleted
-
Rio de Janeiro State UniversityUniversidade Federal do Rio de Janeiro; National Research Council, BrazilCompletedOverweight | Children